当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 资产负债表

科华生物

(002022)

  

流通市值:41.14亿  总市值:41.15亿
流通股本:5.14亿   总股本:5.14亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金1,630,897,436.941,833,734,936.182,280,339,092.422,822,735,743.35
应收票据及应收账款1,103,810,772.731,164,955,947.261,242,282,372.41,286,015,423.81
其中:应收票据1,570,119.220,000,000-358,675
应收账款1,102,240,653.531,144,955,947.261,242,282,372.41,285,656,748.81
应收款项融资35,395,536.565,712,961.9131,332,901.8689,101,194.65
预付款项126,841,472.51121,147,316.52158,469,213.98168,809,601.04
其他应收款合计24,167,288.2427,068,814.3626,630,320.5933,316,819.73
存货975,434,313.491,123,804,210.581,162,046,630.621,152,027,509.77
其他流动资产102,931,061.0895,512,875.792,340,333.98104,070,736.55
流动资产平衡项目0000
流动资产合计4,316,244,225.334,571,937,062.514,993,440,865.855,656,077,028.9
非流动资产:
长期应收款25,728,689.3921,758,122.4329,300,247.7628,023,225.69
其他权益工具投资24,886,90044,617,60044,617,60044,617,600
投资性房地产593,794.5927,868,37928,116,130.9628,379,233.27
固定资产839,009,544.48819,628,075.91820,364,360.84800,532,741.73
在建工程38,302,824.4135,322,109.0534,473,668.325,396,826.07
使用权资产62,574,333.5356,556,242.0862,846,541.2359,360,004.88
无形资产387,840,151.39385,747,622.22383,138,455.87395,596,581.84
开发支出135,244,453.9121,003,793.55120,987,440.46103,613,887.28
商誉695,083,992.93737,327,825.92737,327,825.92728,181,224.29
长期待摊费用45,022,165.9434,914,483.6327,256,516.2615,671,077.15
递延所得税资产225,042,473.3175,182,368.23168,104,098.32152,196,632.07
其他非流动资产12,166,317.156,301,505.247,890,557.116,630,234.84
非流动资产平衡项目0000
非流动资产合计2,491,495,641.012,466,228,127.262,464,423,443.032,388,199,269.11
资产平衡项目0000
资产总计6,807,739,866.347,038,165,189.777,457,864,308.888,044,276,298.01
流动负债:
短期借款45,054,747.5454,779,130.3970,425,101.4154,760,813.86
应付票据及应付账款348,078,839.47310,200,935.16406,292,675.91403,636,633.73
其中:应付票据15,937,456.2516,672,363.5333,987,364.76110,954,122.97
应付账款332,141,383.22293,528,571.63372,305,311.15292,682,510.76
预收款项-128,073.13-128,073.13
合同负债80,438,212.9270,442,931.6696,863,191.99271,303,994.5
应付职工薪酬126,813,714.4785,109,144.38101,469,949.18115,350,564.98
应交税费25,362,989.1331,346,745.5322,966,088.84132,615,539.25
其他应付款合计208,163,846.83258,961,402.15297,408,258.38323,013,087.07
其中:应付利息3,806,627.681,576,161.815,464,049.831,454,972.36
应付股利115,697,150152,000,000192,666,950190,000,000
一年内到期的非流动负债60,447,088.4456,451,710.856,917,615.5652,949,154.34
其他流动负债8,558,732.2810,832,276.5614,940,318.9216,512,325.21
流动负债平衡项目0000
流动负债合计902,918,171.08878,252,349.761,067,283,200.191,370,270,186.07
非流动负债:
长期借款91,979,472.4196,581,358.52110,259,883.0797,110,161.29
应付债券674,648,581.44667,899,380.73660,935,514.62653,666,547.25
租赁负债35,328,996.5532,503,957.9635,670,603.8835,477,996.6
预计负债60,165,296.8974,826,997.7975,026,399.266,519,105.43
递延收益38,212,355.3646,393,686.0445,588,320.5546,337,087.28
递延所得税负债20,263,066.5216,795,645.8617,142,724.7418,007,985.33
非流动负债平衡项目0000
非流动负债合计920,597,769.17935,001,026.9944,623,446.06917,118,883.18
负债平衡项目0000
负债合计1,823,515,940.251,813,253,376.662,011,906,646.252,287,389,069.25
所有者权益(或股东权益):
实收资本(或股本)514,302,062514,298,225514,298,081514,296,856
其他权益工具142,487,463.6142,502,784.97142,503,364.59142,508,387.99
资本公积192,873,731.7193,207,113.83294,425,501.15294,398,560.75
其他综合收益10,787,718.8724,229,049.4329,121,032.698,176,239.81
盈余公积228,578,647.53228,578,647.53228,578,647.53228,578,647.53
未分配利润3,083,087,100.93,296,497,525.673,337,579,730.263,679,792,324.32
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,172,116,724.64,399,313,346.434,546,506,357.224,867,751,016.4
少数股东权益812,107,201.49825,598,466.68899,451,305.41889,136,212.36
股东权益平衡项目0000
股东权益合计4,984,223,926.095,224,911,813.115,445,957,662.635,756,887,228.76
负债和股东权益合计6,807,739,866.347,038,165,189.777,457,864,308.888,044,276,298.01
公告日期2024-03-232023-10-282023-08-172023-04-22
审计意见(境内)标准无保留意见
TOP↑